SON-DP

N/A

Report date: 2024/10/15 11:00:27

Base Information

Drug NameSON-DP
Drug Alias NameREPROGRACON
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQurgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Fuent Pharmaceutical Co LtdQurgen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A